Bio-Connect

ISG20 antibody

GTX114499
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse
TargetISG20
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    ISG20 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.44 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID3669
  • Target name
    ISG20
  • Target description
    interferon stimulated exonuclease gene 20
  • Target synonyms
    CD25; estrogen-regulated transcript 45 protein; HEM45; interferon stimulated exonuclease gene 20kDa; interferon-stimulated gene 20 kDa protein; promyelocytic leukemia nuclear body-associated protein ISG20
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ96AZ6
  • Protein Name
    Interferon-stimulated gene 20 kDa protein
  • Scientific Description
    Exonuclease with specificity for single-stranded RNA and, to a lesser extent for DNA. Degrades RNA at a rate that is approximately 35-fold higher than its rate for single-stranded DNA. Involved in the antiviral function of IFN against RNA viruses.
  • Reactivity
    Human, Mouse
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Expression of interferon-stimulated gene 20 (ISG20), an antiviral effector protein, in glomerular endothelial cells: possible involvement of ISG20 in lupus nephritis.
    Read more
  • ISG20 is overexpressed in clinically relevant radioresistant oral cancer cells. Miyashita H et al., 2020, Int J Clin Exp Pathol
    Read more